Literature DB >> 20349254

Synthesis and cytotoxicity studies of steroid-functionalized titanocenes as potential anticancer drugs: sex steroids as potential vectors for titanocenes.

Li Ming Gao1, José L Vera, Jaime Matta, Enrique Meléndez.   

Abstract

Six titanocenyls functionalized with steroidal esters have been synthesized and characterized by infrared, (1)H, and (13)C NMR spectroscopy and elemental analysis. Among those steroids, dehydroepiandrosterone, trans-androsterone, and androsterone are androgens and pregnenolone is a progesterone precursor. Clionasterol is a natural steroid compound. These steroid-functionalized titanocenyls were tested by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay for in vitro cytotoxicity for MCF-7 breast cancer and HT-29 colon cancer cells. All complexes exhibited more cytotoxicity than titanocene dichloride. The titanocenyls containing androgen and progesterone derivatives as pendant groups had higher antiproliferative activities than those with cholesterol steroid compounds. Of particular significance is titanocenyl-dehydroepiandrosterone complex, which is 2 orders of magnitude more cytotoxic than titanocene dichloride and also shows much more sensitivity and selectivity for the MCF-7 cell line.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349254      PMCID: PMC4461440          DOI: 10.1007/s00775-010-0649-7

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  27 in total

1.  Synthesis, Structure and Biological Activity of Amide-Functionalized Titanocenyls: Improving their Cytotoxic Properties.

Authors:  Li Ming Gao; Jaime Matta; Arnold L Rheingold; Enrique Meléndez
Journal:  J Organomet Chem       Date:  2009-12-15       Impact factor: 2.369

2.  Carbonyl-substituted titanocenes: a novel class of cytostatic compounds with high antitumor and antileukemic activity.

Authors:  Andreas Gansäuer; Iris Winkler; Dennis Worgull; Thorsten Lauterbach; Dieter Franke; Anja Selig; Laura Wagner; Aram Prokop
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

3.  Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines.

Authors:  Shigemasa Yoshida; Akira Honda; Yasushi Matsuzaki; Sugano Fukushima; Naomi Tanaka; Aya Takagiwa; Yoshinori Fujimoto; Hiroshi Miyazaki; Gerald Salen
Journal:  Steroids       Date:  2003-01       Impact factor: 2.668

4.  Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.

Authors:  H Cho; S M Aronica; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1994-02       Impact factor: 4.736

5.  Novel achiral titanocene anti-cancer drugs synthesised from bis-N,N-dimethylamino fulvene and lithiated heterocyclic compounds.

Authors:  Clara Pampillón; James Claffey; Megan Hogan; Matthias Tacke
Journal:  Biometals       Date:  2007-07-31       Impact factor: 2.949

Review 6.  Titanium complexes in cancer treatment.

Authors:  Enrique Meléndez
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

7.  Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies.

Authors:  Thomas Hickey; James Claffey; Eoin Fitzpatrick; Megan Hogan; Clara Pampillón; Matthias Tacke
Journal:  Invest New Drugs       Date:  2007-05-22       Impact factor: 3.850

8.  Synthesis and cytotoxicity studies of new dimethylamino-functionalised and aryl-substituted titanocene anti-cancer agents.

Authors:  Clara Pampillón; James Claffey; Katja Strohfeldt; Matthias Tacke
Journal:  Eur J Med Chem       Date:  2007-03-01       Impact factor: 6.514

9.  Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors.

Authors:  Luis O Gonzalez; Maria D Corte; Julio Vazquez; Sara Junquera; Rosario Sanchez; Ana C Alvarez; Juan C Rodriguez; Maria L Lamelas; Francisco J Vizoso
Journal:  BMC Cancer       Date:  2008-05-28       Impact factor: 4.430

10.  Synthesis, structure, electrochemistry, and cytotoxic properties of ferrocenyl ester derivatives.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  Met Based Drugs       Date:  2009-03-24
View more
  12 in total

1.  Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.

Authors:  Jose F González-Pantoja; Michael Stern; Andrzej A Jarzecki; Eva Royo; Elisa Robles-Escajeda; Armando Varela-Ramírez; Renato J Aguilera; María Contel
Journal:  Inorg Chem       Date:  2011-09-29       Impact factor: 5.165

2.  Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents.

Authors:  Isabel de la Cueva-Alique; Laura Muñoz-Moreno; Yosra Benabdelouahab; Benelita T Elie; Mohammed Amin El Amrani; Marta E G Mosquera; María Contel; Ana M Bajo; Tomás Cuenca; Eva Royo
Journal:  J Inorg Biochem       Date:  2015-12-09       Impact factor: 4.155

3.  Host-Guest Interactions between Calixarenes and Cp(2)NbCl(2).

Authors:  Alexis Morales; Alberto Santana; Gerhard Althoff; Enrique Melendez
Journal:  J Organomet Chem       Date:  2011-07-01       Impact factor: 2.369

Review 4.  A ubiquitous metal, difficult to track: towards an understanding of the regulation of titanium(iv) in humans.

Authors:  Sergio A Loza-Rosas; Manoj Saxena; Yamixa Delgado; Kavita Gaur; Mallesh Pandrala; Arthur D Tinoco
Journal:  Metallomics       Date:  2017-04-19       Impact factor: 4.526

5.  Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.

Authors:  Sergio A Loza-Rosas; Alexandra M Vázquez-Salgado; Kennett I Rivero; Lenny J Negrón; Yamixa Delgado; Josué A Benjamín-Rivera; Angel L Vázquez-Maldonado; Timothy B Parks; Charlene Munet-Colón; Arthur D Tinoco
Journal:  Inorg Chem       Date:  2017-06-23       Impact factor: 5.165

6.  The addition of a pregnenolone pendant group enhances the anticancer properties of titanocene dichloride in a mcf-7 xenograft model.

Authors:  Gladiany Ramos; Yaliz Loperena; Giovanni Ortiz; Fiorella Reyes; Ada Szeto; Jose Vera; Javier Velez; Jessica Morales; Deborah Morrero; Linnette Castillo; Surangani Dharmawardhane; Enrique Melendez; A Valance Washington
Journal:  Anticancer Res       Date:  2014-04       Impact factor: 2.480

7.  Metallocenes as Target Specific Drugs for Cancer Treatment.

Authors:  Enrique Meléndez
Journal:  Inorganica Chim Acta       Date:  2012-06-21       Impact factor: 2.545

8.  Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs.

Authors:  Lauren Fernandez-Vega; Valeria A Ruiz Silva; Tania M Domínguez-González; Sebastián Claudio-Betancourt; Rafael E Toro-Maldonado; Luisa C Capre Maso; Karina Sanabria Ortiz; Jean A Pérez-Verdejo; Janeishly Román González; Grecia T Rosado-Fraticelli; Fabiola Pagán Meléndez; Fabiola M Betancourt Santiago; Daniel A Rivera-Rivera; Carlos Martínez Navarro; Andrea C Bruno Chardón; Axel O Vera; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2020-01-26

9.  On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy.

Authors:  Santiago Gómez-Ruiz; Danijela Maksimović-Ivanić; Sanja Mijatović; Goran N Kaluđerović
Journal:  Bioinorg Chem Appl       Date:  2012-07-12       Impact factor: 7.778

10.  Synthesis and biological evaluation of achiral indole-substituted titanocene dichloride derivatives.

Authors:  Anthony Deally; Frauke Hackenberg; Grainne Lally; Matthias Tacke
Journal:  Int J Med Chem       Date:  2012-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.